 |
Email the Society |
 |
Donations |
ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
Mailing address:
GPO Box 383,
Adelaide,
South Australia 5001
Office:
266 Port Road,
Hindmarsh,
South Australia 5007
Ph: (08) 8346 3237
('834 MECFS')
Office Hours:
Wednesdays, 10am-3pm
Support Line:
(Mondays and Thursdays,
10am-3pm)
Ph: (08) 8346 3237
SA country callers:
Ph: 1300 128 339
(local call)
FIBROMYALGIA HELP: Contact Fibromyalgia SA at the Arthritis Foundation of SA 118 Richmond Road, Marleston 5033 Ph: (08) 8379 5711 |
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
|
Disclaimer
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
| Become a Member | |||
|
Prevalence of fibromyalgia in low socioeconomic status population
Friday 3 July 2009
7thSpace has reprinted an article that was first published in BMC Musculoskeletal Disorders:
Prevalence of fibromyalgia in low socioeconomic status population
The aim of this study was to estimate the prevalence of fibromyalgia, as well as to assess the major symptoms of this syndrome in an adult, low socioeconomic status population assisted by the primary health care system in a city in Brazil.
Methods: We cross-sectionally sampled individuals assisted by the public primary health care system (n=768, 35-60 years old). Participants were interviewed by phone and screened about pain.
They were then invited to be clinically assessed (304 accepted). Pain was estimated using a Visual Analogue Scale (VAS).
Fibromyalgia was assessed using the Fibromyalgia Impact Questionnaire (FIQ), as well as screening for tender points using dolorimetry. Statistical analyses included Bayesian Statistics and the Kruskal-Wallis Anova test (significance level=5%).
Results: From the phone-interview screening, we divided participants (n=768) in three groups: No Pain (NP) (n=185); Regional Pain (RP) (n=388) and Widespread Pain (WP) (n=106).
Among those participating in the clinical assessments, (304 subjects), the prevalence of fibromyalgia was 4.4% (95% confidence interval [2.6%; 6.3%]). Symptoms of pain (VAS and FIQ), feeling well, job ability, fatigue, morning tiredness, stiffness, anxiety and depression were statically different among the groups.
In multivariate analyses we found that individuals with FM and WP had significantly higher impairment than those with RP and NP. FM and WP were similarly disabling.
Similarly, RP was no significantly different than NP.
Conclusion: Fibromyalgia is prevalent in the low socioeconomic status population assisted by the public primary health care system. Prevalence was similar to other studies (4.4%) in a more diverse socioeconomic population.
Individuals with FM and WP have significant impact in their well being.
Author: Ana AssumpcaoAlane CavalcanteCristina CapelaJuliana SauerSuellen ChalotCarlos PereiraAmelia Marques
Credits/Source: BMC Musculoskeletal Disorders 2009, 10:64
This article originally appeared here.
blog comments powered by Disqus
|
More Fibromyalgia News |
Previous Page |
